Bevacizumab ELISA
Enzyme immunoassay for the quantitative determination of free Bevacizumab (Avastin®) in serum and plasma.
The solid phase (MTP) is coated by the target molecule, in this case VEGF.
Reference: IG-AA104
Barcode: 8682754930127
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research, diagnostic and biosimilar uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Instructions for Use IG-AA104 828.05 KB
Material Safety Data Sheet (MSDS) IG-AA104 268.01 KB
Quality Control Certificates
Quality Control Certificate Lot: AA104-108 289.72 KB
Quality Control Certificate Lot: AA104-107 293.08 KB
Quality Control Certificate Lot: AA104-106 333.26 KB
Quality Control Certificate Lot: AA104-105 159.57 KB
Quality Control Certificate Lot: AA104-104 159.55 KB
Quality Control Certificate Lot: AA104-103 160.09 KB
Quality Control Certificate Lot: AA104-102 159.69 KB
Avastin® is a trademark of Genentech Inc./Roche.
The Kit at a glance:
| Required Volume (µL) | 10 |
| Incubation Time (min) | 105 |
| Sample | Serum or Plasma |
| Package Size | 96 Tests |
| Standard Range (µg/mL, 1000x) | 0-200 |
| Sensitivity (ng/mL) | 5 |
| Spike Recovery (%) | >95 |
| Shelf Life (years) | 2 |
Standard Curve:
